| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
77,230,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of product candidates against validated molecular targets in indications of high unmet medical need. AT-007 is a central nervous system penetrant ARI that Co. is developing for the treatment of metabolic diseases, including Galactosemia, a pediatric metabolic disease that affects how the body processes a simple sugar called galactose. AT-001 is an ARI with systemic exposure and peripheral nerve permeability that Co. is developing for the treatment of diabetic cardiomyopathy. AT-003 is an ARI designed to cross through the back of the eye when dosed orally for the treatment of diabetic retinopathy.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
30,000 |
30,000 |
3,691,409 |
| Total Buy Value |
$0 |
$65,367 |
$65,367 |
$3,658,451 |
| Total People Bought |
0 |
1 |
1 |
3 |
| Total Buy Transactions |
0 |
1 |
1 |
5 |
| Total Shares Sold |
506,975 |
933,491 |
1,224,775 |
1,252,098 |
| Total Sell Value |
$2,732,596 |
$3,725,309 |
$4,466,825 |
$4,492,358 |
| Total People Sold |
4 |
6 |
6 |
7 |
| Total Sell Transactions |
4 |
10 |
14 |
18 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Shendelman Shoshana |
President and CEO |
• • • |
2020-02-28 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,000,000 |
709,720 |
|
- |
|
| Shendelman Shoshana |
President and CEO |
• • • |
2020-02-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000,000 |
2,304,285 |
|
- |
|
| Lerner Teena |
Director |
– • – |
2020-02-06 |
4 |
OE |
$1.00 |
$74,712 |
D/D |
30,423 |
49,593 |
|
- |
|
| Marcus Joel S |
Director |
– • – |
2020-01-28 |
4 |
B |
$45.50 |
$22,750 |
D/D |
500 |
405,360 |
2.39 |
- |
|
| Kanter Stacy J. |
Director |
– • – |
2020-01-28 |
4 |
B |
$45.50 |
$295,750 |
D/D |
6,500 |
6,500 |
2.39 |
- |
|
| Shendelman Shoshana |
President and CEO |
• • • |
2019-05-16 |
4/A |
A |
$0.00 |
$0 |
I/I |
88,397 |
88,397 |
|
- |
|
| Funtleyder Leslie D. |
Director |
– • – |
2019-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
4,639 |
13,810 |
|
- |
|
| Marcus Joel S |
Director |
– • – |
2019-05-16 |
4 |
B |
$10.00 |
$1,500,000 |
D/D |
150,000 |
404,860 |
2.39 |
- |
|
| Marcus Joel S |
Director |
– • – |
2019-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
245,689 |
254,860 |
|
- |
|
| Lerner Teena |
Director |
– • – |
2019-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
9,999 |
19,170 |
|
- |
|
| Shendelman Shoshana |
President and CEO |
• • • |
2019-05-16 |
4 |
B |
$10.00 |
$1,250,000 |
D/D |
125,000 |
3,605,662 |
3.23 |
- |
|
| Alexandria Equities No. 7, Llc |
10% Owner |
– – • |
2019-05-16 |
4 |
B |
$10.00 |
$9,750,000 |
I/I |
975,000 |
975,000 |
1.5 |
- |
|
| Alexandria Equities No. 7, Llc |
10% Owner |
– – • |
2019-05-16 |
4 |
A |
$0.00 |
$0 |
I/I |
2,415,576 |
2,415,576 |
|
- |
|
| Shendelman Shoshana |
President and CEOOfficer |
• • • |
2019-05-13 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,270,717 |
|
- |
|
| Shendelman Shoshana |
President and CEOOfficer |
• • • |
2019-05-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,480,662 |
|
- |
|
| Marcus Joel S |
Director |
– • – |
2019-05-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,171 |
|
- |
|
| Funtleyder Leslie D. |
Director |
– • – |
2019-05-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,171 |
|
- |
|
| Lerner Teena |
Director |
– • – |
2019-05-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,171 |
|
- |
|
243 Records found
|
|
Page 10 of 10 |
|
|
